tiprankstipranks
Advertisement
Advertisement

JP:4599 Stock Latest News

StemRIM Wins Mexican Patent for Redasemtide Cartilage Therapy
Company AnnouncementsStemRIM Wins Mexican Patent for Redasemtide Cartilage Therapy
3d ago
4599
StemRIM Secures Canadian Patent for Regenerative Heart Drug Redasemtide
PremiumCompany Announcements
StemRIM Secures Canadian Patent for Regenerative Heart Drug Redasemtide
12d ago
4599
PremiumCompany Announcements
StemRIM Wins South Korean Patent for Gene Therapy Targeting Rare Skin Disorder
17d ago
4599
StemRIM to Record AMED Subsidy as Non-Operating Income for Gene Therapy Project
PremiumCompany Announcements
StemRIM to Record AMED Subsidy as Non-Operating Income for Gene Therapy Project
1M ago
4599
StemRIM Wins Australian Patent for Redasemtide Cartilage Disorder Therapy
PremiumCompany Announcements
StemRIM Wins Australian Patent for Redasemtide Cartilage Disorder Therapy
1M ago
4599
StemRIM Wins Russian Patent to Expand Redasemtide Use in Fatty Liver and NASH
PremiumCompany AnnouncementsStemRIM Wins Russian Patent to Expand Redasemtide Use in Fatty Liver and NASH
1M ago
4599
StemRIM posts continued loss but secures R&D runway through 2028
Premium
Company Announcements
StemRIM posts continued loss but secures R&D runway through 2028
1M ago
4599
StemRIM Plans Tax-Efficient Capital Reduction Ahead of July Extraordinary Meeting
Premium
Company Announcements
StemRIM Plans Tax-Efficient Capital Reduction Ahead of July Extraordinary Meeting
2M ago
4599
StemRIM Highlights Shionogi’s Timelines for Regenerative Drug Redasemtide in DEB and Stroke
PremiumCompany Announcements
StemRIM Highlights Shionogi’s Timelines for Regenerative Drug Redasemtide in DEB and Stroke
2M ago
4599
StemRIM Completes Enrollment in Early-Stage Redasemtide Trial for Ischemic Cardiomyopathy
PremiumCompany Announcements
StemRIM Completes Enrollment in Early-Stage Redasemtide Trial for Ischemic Cardiomyopathy
3M ago
4599
StemRIM Unveils Midterm FY2026 Results and R&D Progress in Regenerative Medicine
PremiumCompany Announcements
StemRIM Unveils Midterm FY2026 Results and R&D Progress in Regenerative Medicine
4M ago
4599
StemRIM narrows interim loss as it ramps R&D on regenerative drug pipeline
PremiumCompany Announcements
StemRIM narrows interim loss as it ramps R&D on regenerative drug pipeline
5M ago
4599
StemRIM Wins Key Patent on Gene Therapy SR-GT1 for Dystrophic Epidermolysis Bullosa
PremiumCompany AnnouncementsStemRIM Wins Key Patent on Gene Therapy SR-GT1 for Dystrophic Epidermolysis Bullosa
5M ago
4599
StemRIM Wins Canadian Patent for Redasemtide Use in Cartilage Disorders
Premium
Company Announcements
StemRIM Wins Canadian Patent for Redasemtide Use in Cartilage Disorders
5M ago
4599
StemRIM Completes Global Phase 2b Enrollment for Stroke Drug Redasemtide
Premium
Company Announcements
StemRIM Completes Global Phase 2b Enrollment for Stroke Drug Redasemtide
7M ago
4599
StemRIM Secures Patent for Innovative Fatty Liver and NASH Therapy in Japan
PremiumCompany Announcements
StemRIM Secures Patent for Innovative Fatty Liver and NASH Therapy in Japan
7M ago
4599
StemRIM Inc. Reports Q3 2025 Financial Results Amid Ongoing R&D Investments
PremiumCompany Announcements
StemRIM Inc. Reports Q3 2025 Financial Results Amid Ongoing R&D Investments
8M ago
4599
StemRIM Completes New Share Issuance for Stock Compensation
PremiumCompany Announcements
StemRIM Completes New Share Issuance for Stock Compensation
8M ago
4599
StemRIM Inc. Forms Voluntary Compensation Committee to Enhance Governance
PremiumCompany Announcements
StemRIM Inc. Forms Voluntary Compensation Committee to Enhance Governance
8M ago
4599
StemRIM Inc. Unveils Revolutionary Regenerative Medicine Plan
PremiumCompany AnnouncementsStemRIM Inc. Unveils Revolutionary Regenerative Medicine Plan
8M ago
4599
StemRIM Inc. Issues New Shares for Restricted Stock Remuneration
Premium
Company Announcements
StemRIM Inc. Issues New Shares for Restricted Stock Remuneration
8M ago
4599
StemRIM Secures Patent for Innovative Gene Therapy Targeting Skin Disorder
Premium
Company Announcements
StemRIM Secures Patent for Innovative Gene Therapy Targeting Skin Disorder
9M ago
4599

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >